Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6900
+0.0200 (1.20%)
NASDAQ · Last Trade: Feb 17th, 4:29 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors